December 29, 2017 / 6:18 PM / 23 days ago

BRIEF-Immunoprecise To Strategically Invest In Serpinx B.V.

Immunoprecise Antibodies Ltd:

* IMMUNOPRECISE TO STRATEGICALLY INVEST IN SERPINX B.V.

* IMMUNOPRECISE ANTIBODIES - TO “STRATEGICALLY” INVEST WITH SERPINX B.V. IN DEVELOPING RECOMBINANT PROTEASE INHIBITORS TO TREAT BRADYKININ MEDIATED DISEASES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below